In seven patients, there were no signs of toxicity with proton-beam radioablation, clearing the way for future studies.

In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of th ...

Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation ...

Adagio Medical reports positive pivotal results for vCLAS Ventricular Ablation System: Laguna Hills, California Tuesday, April 28, 2026, 17:00 Hrs [IST] Adagio Medical Holdings, I ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...

A novel technique called stereotactic arrhythmia radiation therapy (STAR) is emerging as a potential alternative to catheter ablation for patients with life-threatening ventricular tachycardia that ...

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...

Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...

May 6, 2011 (San Francisco, California) — Ablation of ventricular tachycardia (VT) in patients with verylow ejection fractions (EFs) results in high rates of early recurrence compared with individuals ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...